Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Genetically Defined Metabolic Targets Overcome Ibrutinib Resistance in Mantle Cell Lymphoma

Liang Zhang, MD PhD, Hui Guo, PhD, Hui Zhang, Yixin Yao, PhD, Yang Liu, MD, Shaojun Zhang, PhD, Lixin Rui, PhD, Linghua Wang, PhD, Krystle Nomie, PhD, Michael L. Wang, MD

Blood (2019) 134 (Supplement_1): 395.

https://doi.org/10.1182/blood-2019-125934

Published: 2019

Journal Articles

Ibrutinib-Resistant Mantle Cell Lymphoma Undergoes Metabolic Reprogramming Towards Oxphos

Krystle Nomie, PhD, Liang Zhang, MD PhD, Yixin Yao, PhD, Yang Liu, PhD, Shaojun Zhang, PhD, Hui Zhang, Hui Guo, PhD, Makhdum Ahmed, MDPhDMPH, Maria Badillo, Linghua Wang, PhD, Michael Wang, MD

Blood (2018) 132 (Supplement 1): 41.

https://doi.org/10.1182/blood-2018-99-117279

Published: 2018

Journal Articles

Unravelling the Heterogeneity of Mantle Cell Lymphoma Ecosystem By Single Cell RNA Sequencing

Makhdum Ahmed, MD PhD MPH, Hui Guo, PhD, Shaojun Zhang, PhD, Lalit Sehgal, PhD MPhil, Preetesh Jain, MBBS, MDDM, PhD, Rashmi Kanagal-Shamanna, MD, Chi Young Ok, MD, Angela Leeming, Yixin Yao, PhD, Liang Zhang, MD PhD, Krystle Nomie, PhD, Linghua Wang, PhD, Michael Wang, MD

Blood (2018) 132 (Supplement 1): 4118.

https://doi.org/10.1182/blood-2018-99-110540

Published: 2018

Journal Articles

FoxM1-Mediated Signaling Promotes the Progression of Mantle Cell Lymphoma

Hui Guo, PhD, Yixin Yao, PhD, Hui Zhang, Elizabeth Lorence, Makhdum Ahmed, MD PhD MPH, Lingyan Ping, MD PhD, Krystle Nomie, PhD, Liang Zhang, MD PhD, Michael Wang, MD

Blood (2018) 132 (Supplement 1): 4176.

https://doi.org/10.1182/blood-2018-99-119349

Published: 2018

Journal Articles

A Novel Patient-Derived Xenograft Model of Secondary CD20 - CNS Lymphoma for Mechanistic and Therapeutic Exploration

Liang Zhang, MD PhD, Hui Zhang, Hui Guo, PhD, Yuting Sun, PhD, Ningping Feng, PhD, Joseph R Marszalek, PhD, Makhdum Ahmed, MDPhDMPH, Krystle Nomie, PhD, Michael Wang, MD

Blood (2018) 132 (Supplement 1): 1669.

https://doi.org/10.1182/blood-2018-99-112205

Published: 2018

Journal Articles

Metabolic Profiling Identifies De Novo Nucleotide Synthesis As a Potential Metabolic Vulnerability for Targeted Therapy Against Mantle Cell Lymphoma

Yixin Yao, PhD, Yang Liu, PhD, Hui Guo, PhD, Makhdum Ahmed, MD PhD MPH, Shabnam Bhuiyan, MSc, Krystle Nomie, PhD, Liang Zhang, MD PhD, Michael Wang, MD

Blood (2018) 132 (Supplement 1): 2945.

https://doi.org/10.1182/blood-2018-99-112192

Published: 2018

Journal Articles

Inhibition of B-Cell Receptor Signaling Disrupts Cell Adhesion in Mantle Cell Lymphoma Via RAC2

Weige Wang, MD, Franzen Carrie, Hui Guo, PhD, Jimmy Lee, MD, Yan Li, Madina Sukhanova, PhD, Dong Sheng, MD, Girish Venkataraman, MD MBBS, Ming Mei, Pin Lu, PhD, Anhui Gao, Chunmei Xia, Li Jia, Liang Zhang, MD PhD, Michael Wang, MD, Jorge Andrade, Zhou Xiaoyan, Y. Lynn Lynn Wang, MDPhD

Blood (2018) 132 (Supplement 1): 1369.

https://doi.org/10.1182/blood-2018-99-118598

Published: 2018

Journal Articles

Targeting the Paracaspase MALT1: A Potential Therapy to Overcome Ibrutinib Resistance in Relapsed/Refractory Mantle Cell Lymphoma Patients

Changying Jiang, PhD, Shengjian Huang, PhD, Yang Liu, MD, Carrie Li, Hui Guo, MD PhD, Jeffrey Wang, Elyse Lopez, Hui Zhang, Elizabeth A Lorence, MPH, Maria Merolle, Swathi Balaji, Makhdum Ahmed, MD MPH, PhD, Krystle Nomie, PhD, Xin Lin, PhD, Liang Zhang, MD PhD, Michael Wang, MD

Blood (2017) 130 (Supplement 1): 574.

https://doi.org/10.1182/blood.V130.Suppl_1.574.574

Published: 2017

Journal Articles

FoxM1: A New Therapeutic Target for Mantle Cell Lymphoma

Hui Guo, MD PhD, Hui Zhang, Makhdum Ahmed, MD MPH, PhD, Yang Liu, MD, Shengjian Huang, PhD, Victoria Zhang, Jeffrey Wang, Elyse Lopez, Elizabeth A Lorence, MPH, Jacqueline Wang, Swathi Balaji, Merolle Maria, Changying Jiang, PhD, Krystle Nomie, PhD, Michael Wang, BS, Liang Zhang, MD PhD

Blood (2017) 130 (Supplement 1): 1469.

https://doi.org/10.1182/blood.V130.Suppl_1.1469.1469

Published: 2017

Journal Articles

Molecular Pathways Associated with Ibrutinib Resistance in Mantle Cell Lymphoma

Liang Zhang, MD PhD, Krystle Nomie, PhD, Shaojun Zhang, PhD, Yang Liu, MD, Hui Guo, MD PhD, Shengjian Huang, PhD, Jeffrey Wang, Elyse Lopez, Hui Zhang, Elizabeth A Lorence, MPH, Maria Merolle, Swathi Balaji, Makhdum Ahmed, MD MPH, PhD, Changying Jiang, PhD, Linghua Wang, Michael Wang, MD

Blood (2017) 130 (Supplement 1): 2738.

https://doi.org/10.1182/blood.V130.Suppl_1.2738.2738

Published: 2017

Journal Articles

Resistance Mechanisms Underlying Venetoclax Resistance in Mantle Cell Lymphoma

Shengjian Huang, PhD, Changying Jiang, PhD, Hui Guo, MD PhD, Jeffrey Wang, Yang Liu, MD, Carrie Li, Elyse Lopez, Hui Zhang, Elizabeth A Lorence, MPH, Maria Merolle, Swathi Balaji, Makhdum Ahmed, MD MPH, PhD, Krystle Nomie, PhD, Liang Zhang, MD PhD, Michael Wang, MD

Blood (2017) 130 (Supplement 1): 2749.

https://doi.org/10.1182/blood.V130.Suppl_1.2749.2749

Published: 2017

Journal Articles

Genetic and Molecular Characterization of Ibrutinib-Resistant Mantle Cell Lymphoma: Designing Innovative Therapeutic Strategies

Hui Guo, MD PhD, Shengjian Huang, Yang Liu, PhD, Carrie J Li, Jack Wang, Victoria Zhang, Makhdum Ahmed, MD MPH, Laura T Lam, PhD, Hui Zhang, Krystle Nomie, PhD, Liang Zhang, MD PhD, Michael Wang, MD

Blood (2016) 128 (22): 1838.

https://doi.org/10.1182/blood.V128.22.1838.1838

Published: 2016

Journal Articles

Patient-Derived Xenograft Model in B-Cell Lymphoma: A Platform for a Personalized Clinical Trial

Taylor Bell, Hui Zhang, Makhdum Ahmed, MD MPH, Hui Guo, MD PhD, Carrie J Li, Yang Liu, PhD, Laura T Lam, PhD, Zhihong Chen, Jack Wang, Victoria Zhang, Krystle Nomie, PhD, Liang Zhang, MD PhD, Michael Wang, MD

Blood (2016) 128 (22): 1839.

https://doi.org/10.1182/blood.V128.22.1839.1839

Published: 2016

Journal Articles

Novel Bruton's Tyrosine Kinase Inhibitor Bgb-3111 Demonstrates Potent Activity in Mantle Cell Lymphoma

Carrie J Li, Yang Liu, PhD, Taylor Bell, Jack Wang, Hui Guo, MD PhD, Makhdum Ahmed, MD MPH, Hui Zhang, Laura T Lam, PhD, Krystle Nomie, PhD, Lai Wang, PhD, Liang Zhang, MD PhD, Michael Wang, MD

Blood (2016) 128 (22): 5374.

https://doi.org/10.1182/blood.V128.22.5374.5374

Published: 2016

Journal Articles

Pre-Clinical Evaluation of the PI3K-p110β/δ Inhibitor KA2237 in Mantle Cell Lymphoma

Shengjian Huang, Loretta J. Nastoupil, MD, Hui Guo, MD PhD, Taylor Bell, Makhdum Ahmed, MD MPH, Carrie J Li, Jack Wang, Yang Liu, PhD, Victoria Zhang, Caroline R Kim, Jordan N Boyle, Elizabeth A Lorence, Laura T Lam, PhD, Zhihong Chen, Hui Zhang, Stephen Joseph Shuttleworth, PhD, Krystle Nomie, PhD, Michael Wang, MD, Liang Zhang, MD PhD

Blood (2016) 128 (22): 1837.

https://doi.org/10.1182/blood.V128.22.1837.1837

Published: 2016

Journal Articles

The Effects of PI3K-δ/γ Inhibitor, Duvelisib, in Mantle Cell Lymphoma in Vitro and in Patient-Derived Xenograft Studies

Jack Wang, Victoria Zhang, Taylor Bell, Yang Liu, PhD, Hui Guo, MD PhD, Liang Zhang, MD PhD

Blood (2016) 128 (22): 3016.

https://doi.org/10.1182/blood.V128.22.3016.3016

Published: 2016

Journal Articles

Targeting Oxphos Pathway Against Ibrutinib Resistance to Mantle Cell Lymphoma

Yang Liu, PhD, Taylor Bell, Hui Zhang, Yuting Sun, Carrie J Li, Ningping Feng, PhD, Shengjian Huang, Hui Guo, MD PhD, Jack Wang, Makhdum Ahmed, MD MPH, Victoria Zhang, Laura T Lam, PhD, Krystle Nomie, PhD, Liang Zhang, MD PhD, Maria E Di Francesco, Joe Marszalek, Michael Wang, MD

Blood (2016) 128 (22): 290.

https://doi.org/10.1182/blood.V128.22.290.290

Published: 2016

Journal Articles

CUDC-907: An Oral HDAC/PI3K Dual Inhibitor with Strong Preclinical Efficacy in MCL Model

Jordan N Boyle, Caroline R Kim, Hui Guo, MD PhD, Taylor Bell, Shengjian Huang, Carrie J Li, Yang Liu, PhD, Hui Zhang, Jack Wang, Victoria Zhang, Makhdum Ahmed, MD MPH, Laura T Lam, PhD, Krystle Nomie, PhD, Liang Zhang, MD PhD, Dongfeng Zeng, Michael Wang, MD

Blood (2016) 128 (22): 4183.

https://doi.org/10.1182/blood.V128.22.4183.4183

Published: 2016

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Genetically Defined Metabolic Targets Overcome Ibrutinib Resistance in Mantle Cell Lymphoma

Ibrutinib-Resistant Mantle Cell Lymphoma Undergoes Metabolic Reprogramming Towards Oxphos

Unravelling the Heterogeneity of Mantle Cell Lymphoma Ecosystem By Single Cell RNA Sequencing

FoxM1-Mediated Signaling Promotes the Progression of Mantle Cell Lymphoma

A Novel Patient-Derived Xenograft Model of Secondary CD20 - CNS Lymphoma for Mechanistic and Therapeutic Exploration

Metabolic Profiling Identifies De Novo Nucleotide Synthesis As a Potential Metabolic Vulnerability for Targeted Therapy Against Mantle Cell Lymphoma

Inhibition of B-Cell Receptor Signaling Disrupts Cell Adhesion in Mantle Cell Lymphoma Via RAC2

Targeting the Paracaspase MALT1: A Potential Therapy to Overcome Ibrutinib Resistance in Relapsed/Refractory Mantle Cell Lymphoma Patients

FoxM1: A New Therapeutic Target for Mantle Cell Lymphoma

Molecular Pathways Associated with Ibrutinib Resistance in Mantle Cell Lymphoma

Resistance Mechanisms Underlying Venetoclax Resistance in Mantle Cell Lymphoma

Genetic and Molecular Characterization of Ibrutinib-Resistant Mantle Cell Lymphoma: Designing Innovative Therapeutic Strategies

Patient-Derived Xenograft Model in B-Cell Lymphoma: A Platform for a Personalized Clinical Trial

Novel Bruton's Tyrosine Kinase Inhibitor Bgb-3111 Demonstrates Potent Activity in Mantle Cell Lymphoma

Pre-Clinical Evaluation of the PI3K-p110β/δ Inhibitor KA2237 in Mantle Cell Lymphoma

The Effects of PI3K-δ/γ Inhibitor, Duvelisib, in Mantle Cell Lymphoma in Vitro and in Patient-Derived Xenograft Studies

Targeting Oxphos Pathway Against Ibrutinib Resistance to Mantle Cell Lymphoma

CUDC-907: An Oral HDAC/PI3K Dual Inhibitor with Strong Preclinical Efficacy in MCL Model

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only